- Email: [email protected]
High Moisture Management Properties of a Semi-Permeable Transparent Film Dressing Featuring Chlorhexidine Gluconate Within the Adhesive
rate. 182 midlines with a dwell time of 5 to 29 days were included in this data. Results: With TKO anti-reflux connectors, midline blood draw capability lasted almost as long as the life of the catheter, regardless of dwell time. Smaller catheter size was associated with a consistently higher rate of blood sampling and a higher IV therapy completion rate. Discussion: d Midlines were an effective alternative to unnecessary PICC placements, and reduced overall central line catheter days. d TKO connectors allowed us to extend blood sampling capability far longer than the expectations set by the midline manufacturers. d The smallest gauge midline catheters had the highest rate of blood sampling and highest IV therapy completion rate. This suggests that the anti-reflux properties of the TKO connector, in combination with the smaller gauge catheters, maximized blood return by reducing thrombosis. d 1/3 of midlines were discontinued in 4 days, representing a vascular access need that may be better met with a less costly shorter dwell U/S guided PIV. Limitations: Vessel size to catheter ratio was not factored. Secondly, 45% of total midlines were discontinued within 4 days or were present at discharge and therefore not included in our study. A third limitation was the lack of comparative data. Further study could include a randomized comparison between at least two different connectors. Conclusion: d Catheter-to-vein ratio is an important factor in maximizing midline function d TKO anti-reflux connector maximizes blood draw capability of midlines
Verifying PICC Line Placement Using ECG Technology Lucy Van Elzen, RN, VA-CC, Shanti Lackey, RN, BSN, CRNIÒ, and Amy Vanterpool, RN, BSN, CEN, CFRN Background: In 2006 our hospital based PICC team began placing PICC lines at bedside using ultrasound and the Sherlock navigation system. Upon completion of catheter placement a chest x-ray was required to confirm catheter tip location. This caused a delay in catheter release to the staff for use. In 2013 we got administrative support to incorporate ECG technology. The ECG technology provides real time catheter tip location by using the patient’s cardiac electrical activity, thereby providing immediate release of the catheter for use and the elimination of a chest x-ray. Purpose: For the patients requiring PICC line placement, does 3CG technology vs. the Sherlock navigation system decrease the time to catheter release, decrease patient radiation exposure and provide cost savings. Project/Case: A proposal was presented to the Radiology staff to introduce and begin a trial of the ECG technology. Didactic training was provided by the 3CG clinical educators. Each RN placed at least 5 PICC lines using 3CG technology that corresponded to chest x-ray catheter tip confirmation. Results: 1. Immediate bedside confirmation of catheter tip position in the lower 1/3 of the superior vena cava and release of the catheter for patient care.
2. Decreased radiation exposure and costs associated with radiologic exams. (Exclusions for ECG tip location include patients with atrial fibrillation; flutter; or pacemaker driven rhythms.) 3. Decreased nursing staff time spent waiting for confirmation readings. Implications: PICC lines that meet the insertion parameters are now released for immediate use after placement. Conclusions: Our small facility saw a total cost savings of $55,476 using 3CG technology in 2014. We have decreased our patient chest x-rays from 50 per month to less than 5 on average. Catheter release has gone from approximately 60 minutes to immediate.
High Moisture Management Properties of a Semi-Permeable Transparent Film Dressing Featuring Chlorhexidine Gluconate Within the Adhesive Anne Wibaux Purpose: The BeneHoldÔ CHG Transparent Film Dressing is a new IV transparent dressing featuring a novel adhesive which has absorptive properties and chlorhexidine gluconate (CHG) incorporated. The benefit of this new dressing is it can absorb fluid and provide CHG through a simple semipermeable transparent film dressing. This study evaluates both the dressing’s in-vitro antimicrobial efficacy in comparison to a CHG-impregnated gel and dressing’s moisture management properties in comparison to transparent semipermeable polyurethane film dressing and a hydrocolloid. Methods: Standards EN13726 and Jis Z2801:2010 were used for this study. Results: BeneHoldTM CHG Transparent Film Dressing has demonstrated - Greater than 4.0 Log10 reduction on bacteria from day 1 through day 7; equivalent to that of a CHG-impregnated gel. - Fluid Handling Capacity, sum of the moisture vapor transmission rate (MVTR) and static absorption, equivalent to that of an advanced wound care hydrocolloid. Limitations: The study was conducted In vitro. Conclusion: The BeneHoldÔ CHG Transparent Film Dressing containing chlorhexidine gluconate, demonstrated antimicrobial efficacy similar to that of CHG-impregnated gel. Additionally the BeneHoldÔ dressing provides high moisture management equivalent to that of an advanced wound care hydrocolloid. This technology has the potential to simplify treatment and improve patient care by combining absorption, breathability, and antimicrobial properties in one simple product. Ó2015 Avery Dennison Corporation. BeneHold is a trademark of Avery Dennison Corporation.
The Implementation of Near-Infrared Technology to Decrease PICC Line Placements on Patients With Limited Venous Patti Wilcox Background: It was identified that a significant number of patients were requiring PICC line placements due to poor venous access at our institution. Research was initiated to investigate
2015
j
Vol 20 No 4
j
JAVA
j
249
Verifying PICC Line Placement Using ECG Technology Lucy Van Elzen, RN, VA-CC, Shanti Lackey, RN, BSN, CRNIÒ, and Amy Vanterpool, RN, BSN, CEN, CFRN Background: In 2006 our hospital based PICC team began placing PICC lines at bedside using ultrasound and the Sherlock navigation system. Upon completion of catheter placement a chest x-ray was required to confirm catheter tip location. This caused a delay in catheter release to the staff for use. In 2013 we got administrative support to incorporate ECG technology. The ECG technology provides real time catheter tip location by using the patient’s cardiac electrical activity, thereby providing immediate release of the catheter for use and the elimination of a chest x-ray. Purpose: For the patients requiring PICC line placement, does 3CG technology vs. the Sherlock navigation system decrease the time to catheter release, decrease patient radiation exposure and provide cost savings. Project/Case: A proposal was presented to the Radiology staff to introduce and begin a trial of the ECG technology. Didactic training was provided by the 3CG clinical educators. Each RN placed at least 5 PICC lines using 3CG technology that corresponded to chest x-ray catheter tip confirmation. Results: 1. Immediate bedside confirmation of catheter tip position in the lower 1/3 of the superior vena cava and release of the catheter for patient care.
2. Decreased radiation exposure and costs associated with radiologic exams. (Exclusions for ECG tip location include patients with atrial fibrillation; flutter; or pacemaker driven rhythms.) 3. Decreased nursing staff time spent waiting for confirmation readings. Implications: PICC lines that meet the insertion parameters are now released for immediate use after placement. Conclusions: Our small facility saw a total cost savings of $55,476 using 3CG technology in 2014. We have decreased our patient chest x-rays from 50 per month to less than 5 on average. Catheter release has gone from approximately 60 minutes to immediate.
High Moisture Management Properties of a Semi-Permeable Transparent Film Dressing Featuring Chlorhexidine Gluconate Within the Adhesive Anne Wibaux Purpose: The BeneHoldÔ CHG Transparent Film Dressing is a new IV transparent dressing featuring a novel adhesive which has absorptive properties and chlorhexidine gluconate (CHG) incorporated. The benefit of this new dressing is it can absorb fluid and provide CHG through a simple semipermeable transparent film dressing. This study evaluates both the dressing’s in-vitro antimicrobial efficacy in comparison to a CHG-impregnated gel and dressing’s moisture management properties in comparison to transparent semipermeable polyurethane film dressing and a hydrocolloid. Methods: Standards EN13726 and Jis Z2801:2010 were used for this study. Results: BeneHoldTM CHG Transparent Film Dressing has demonstrated - Greater than 4.0 Log10 reduction on bacteria from day 1 through day 7; equivalent to that of a CHG-impregnated gel. - Fluid Handling Capacity, sum of the moisture vapor transmission rate (MVTR) and static absorption, equivalent to that of an advanced wound care hydrocolloid. Limitations: The study was conducted In vitro. Conclusion: The BeneHoldÔ CHG Transparent Film Dressing containing chlorhexidine gluconate, demonstrated antimicrobial efficacy similar to that of CHG-impregnated gel. Additionally the BeneHoldÔ dressing provides high moisture management equivalent to that of an advanced wound care hydrocolloid. This technology has the potential to simplify treatment and improve patient care by combining absorption, breathability, and antimicrobial properties in one simple product. Ó2015 Avery Dennison Corporation. BeneHold is a trademark of Avery Dennison Corporation.
The Implementation of Near-Infrared Technology to Decrease PICC Line Placements on Patients With Limited Venous Patti Wilcox Background: It was identified that a significant number of patients were requiring PICC line placements due to poor venous access at our institution. Research was initiated to investigate
2015
j
Vol 20 No 4
j
JAVA
j
249